Medtech Acquisition Corp Stock Net Asset
| MTACDelisted Stock | USD 10.55 0.03 0.28% |
MedTech Acquisition Corp fundamentals help investors to digest information that contributes to MedTech Acquisition's financial success or failures. It also enables traders to predict the movement of MedTech Stock. The fundamental analysis module provides a way to measure MedTech Acquisition's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MedTech Acquisition stock.
MedTech |
MedTech Acquisition Corp Company Net Asset Analysis
MedTech Acquisition's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current MedTech Acquisition Net Asset | 20.19 M |
Most of MedTech Acquisition's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MedTech Acquisition Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, MedTech Acquisition Corp has a Net Asset of 20.19 M. This is much higher than that of the Capital Markets sector and significantly higher than that of the Financials industry. The net asset for all United States stocks is notably lower than that of the firm.
MedTech Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MedTech Acquisition's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MedTech Acquisition could also be used in its relative valuation, which is a method of valuing MedTech Acquisition by comparing valuation metrics of similar companies.MedTech Acquisition is currently under evaluation in net asset category among its peers.
MedTech Fundamentals
| Return On Asset | -0.0193 | |||
| Current Valuation | 79.84 M | |||
| Shares Outstanding | 7.39 M | |||
| Shares Owned By Insiders | 84.51 % | |||
| Shares Owned By Institutions | 17.16 % | |||
| Number Of Shares Shorted | 2.85 K | |||
| Price To Earning | 31.28 X | |||
| Price To Book | 1.31 X | |||
| EBITDA | (8.58 M) | |||
| Net Income | 5.54 M | |||
| Cash And Equivalents | 69.18 K | |||
| Total Debt | 2.37 M | |||
| Debt To Equity | 1.77 % | |||
| Current Ratio | 0.15 X | |||
| Book Value Per Share | (2.42) X | |||
| Cash Flow From Operations | (2.74 M) | |||
| Short Ratio | 1.00 X | |||
| Earnings Per Share | 0.05 X | |||
| Beta | -0.0423 | |||
| Market Capitalization | 83.86 M | |||
| Total Asset | 20.19 M | |||
| Retained Earnings | (13.27 M) | |||
| Working Capital | (2.14 M) | |||
| Z Score | 18.76 | |||
| Net Asset | 20.19 M |
About MedTech Acquisition Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MedTech Acquisition Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MedTech Acquisition using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MedTech Acquisition Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in MedTech Stock
If you are still planning to invest in MedTech Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MedTech Acquisition's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |